Nothing Special   »   [go: up one dir, main page]

van der Velden et al., 2007 - Google Patents

Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3β

van der Velden et al., 2007

View HTML
Document ID
5192648840849847304
Author
van der Velden J
Langen R
Kelders M
Willems J
Wouters E
Janssen-Heininger Y
Schols A
Publication year
Publication venue
American Journal of Physiology-Cell Physiology

External Links

Snippet

Muscle atrophy contributes to morbidity and mortality in aging and chronic disease, emphasizing the need to gain understanding of the mechanisms involved in muscle atrophy and (re) growth. We hypothesized that the magnitude of muscle regrowth during recovery …
Continue reading at journals.physiology.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
van der Velden et al. Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3β
van der Velden et al. Inhibition of glycogen synthase kinase-3β activity is sufficient to stimulate myogenic differentiation
Verhees et al. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy
Frost et al. Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass
Boura-Halfon et al. Phosphorylation of IRS proteins, insulin action, and insulin resistance
Helman et al. Effects of ageing and senescence on pancreatic β‐cell function
Dogra et al. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-κB and degradation of MyoD protein
Thomson et al. AMP-activated protein kinase phosphorylates transcription factors of the CREB family
Van Wessel et al. The muscle fiber type–fiber size paradox: hypertrophy or oxidative metabolism?
Baeza-Raja et al. p38 MAPK-induced nuclear factor-κB activity is required for skeletal muscle differentiation: role of interleukin-6
Perry et al. Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise
Guttridge Signaling pathways weigh in on decisions to make or break skeletal muscle
Chen et al. TNF-α regulates myogenesis and muscle regeneration by activating p38 MAPK
Theeuwes et al. Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism
Serra et al. Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation
Glass et al. Recent advances in the biology and therapy of muscle wasting
Sartori et al. Smad2 and 3 transcription factors control muscle mass in adulthood
Arthur et al. The effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repair
Acharyya et al. Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome
Zhuo et al. MicroRNA-451 negatively regulates hepatic glucose production and glucose homeostasis by targeting glycerol kinase–mediated gluconeogenesis
Haddad et al. Selected contribution: acute cellular and molecular responses to resistance exercise
Manoli et al. Mitochondria as key components of the stress response
Langen et al. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation
Marimuthu et al. Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans
Wilson et al. Selective control of skeletal muscle differentiation by Akt1